Free Trial

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$11.80 -0.26 (-2.16%)
As of 03/10/2025 03:59 PM Eastern

DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNN

Should you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry.

DRI Healthcare Trust vs.

DRI Healthcare Trust (TSE:DHT.UN) and Abattis Bioceuticals (CNSX:ATT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, community ranking, dividends, profitability and analyst recommendations.

48.4% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Abattis Bioceuticals received 68 more outperform votes than DRI Healthcare Trust when rated by MarketBeat users. However, 77.27% of users gave DRI Healthcare Trust an outperform vote while only 64.89% of users gave Abattis Bioceuticals an outperform vote.

CompanyUnderperformOutperform
DRI Healthcare TrustOutperform Votes
17
77.27%
Underperform Votes
5
22.73%
Abattis BioceuticalsOutperform Votes
85
64.89%
Underperform Votes
46
35.11%

DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Abattis Bioceuticals N/A N/A N/A

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Abattis Bioceuticals. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Abattis Bioceuticals. DRI Healthcare Trust's average media sentiment score of 1.61 beat Abattis Bioceuticals' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Very Positive
Abattis Bioceuticals Neutral

DRI Healthcare Trust presently has a consensus target price of C$17.94, suggesting a potential upside of 52.01%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, research analysts clearly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Abattis Bioceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-236.00
Abattis BioceuticalsN/AN/AN/AN/AN/A

Summary

DRI Healthcare Trust beats Abattis Bioceuticals on 12 of the 13 factors compared between the two stocks.

Remove Ads
Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

MetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapN/AC$2.32BC$5.72BC$5.54B
Dividend Yield3.26%2.92%4.89%6.46%
P/E Ratio-236.004.2524.9029.32
Price / SalesN/A675.17401.45457.10
Price / CashN/A10.2538.0583.08
Price / Book1.277.227.273.48
Net IncomeC$9.73MC$20.70BC$3.19BC$299.31M
7 Day Performance-2.64%-1.72%-0.20%-0.95%
1 Month Performance-0.17%-2.93%-5.99%-4.87%
1 Year Performance-27.25%90.01%11.72%26.68%

DRI Healthcare Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
1.9754 of 5 stars
C$11.80
-2.2%
C$17.94
+52.0%
-28.1%C$0.00C$193.66M-236.00N/ANews Coverage
Positive News
ATT
Abattis Bioceuticals
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Up
AGRA
Agraflora Organics International
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
MJ
Amplify Alternative Harvest ETF
N/AN/AN/AN/A$0.00N/A0.007Gap Up
BIO
Bio-Rad Laboratories
N/AN/AN/AN/A$0.00N/A0.008,000High Trading Volume
BBM
Blueberries Medical
N/AN/AN/AN/A$0.00N/A0.008News Coverage
High Trading Volume
BAMM
BooksAMillion
N/AN/AN/AN/A$0.00N/A0.00142High Trading Volume
LOVE
Cannara Biotech
N/AN/AN/AN/A$0.00N/A0.00N/APositive News
High Trading Volume
CSI
Chemesis International
N/AN/AN/AN/A$0.00N/A0.00147,000Gap Down
High Trading Volume
CALI
China Auto Logistics
N/AN/AN/AN/A$0.00N/A0.0040Gap Down
High Trading Volume
DCNN
Digicann Ventures
N/AN/AN/AN/A$0.00N/A0.00N/A
Remove Ads

Related Companies and Tools


This page (TSE:DHT.UN) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners